GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Solvonis Therapeutics SVNS.L · GBp

Materials · LSE · 🇬🇧 United Kingdom

Compare

0.10p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Solvonis Therapeutics — daily SVNS

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Solvonis Therapeutics on TradingView ↗
Market value
£6.5m
Last close × shares
Volume
10.8m
Shares, 9 Nov 2026

About Solvonis Therapeutics

Its shares trade on LSE under the ticker SVNS.L. It has been listed since 6 January 2022. In the fiscal year to 31 December 2023, it reported revenue of £587,000 and a net loss of £3.1m. At that date it held total assets of £2.4m and shareholders' equity of £2.0m.

Graft Polymer (UK) Ltd. is a holding company, which engages in the development and production of polymer. The firm offers bespoke, adapted, and tailored products for customer requests. Its products pipeline includes GRAFTABOND, GRAFTAPOR, GRAFTALEN, GRAFTAKIT, GRAFTALLOY, GRAFTAMID, GRAFTASYNT and GRAFTAMER. GRAFTABOND product is a graft / block copolymers (adhesion promotors) for combining various polymers (with fiberglass, carbon fiber, mineral and natural fillers, mixed polymer waste. The GRAFTAPOR product is a porous polymer carriers for many liquid chemicals. Its GRAFTALEN is a reactive solid super concentrates for polyolefin rheology modification, e-modulus enhancer, polybutylene terephthalate chain extender, AOX masterbatch. GRAFTAKIT is a reactive liquid or solid super concentrates on polymeric porous media for carrying out reaction extrusion and modification of compounds.

Figures and description from our data supplier, not checked against the company's own report.

More about Solvonis Therapeutics →

Latest on Solvonis Therapeutics

Our reporting

We have not reported on Solvonis Therapeutics yet.

Next results

30 Jun 2027

Due on 30 Jun 2027.

Other Materials listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Solvonis Therapeutics's ticker?

Solvonis Therapeutics trades as SVNS.L on LSE, under ISIN GB00BMD1Z199.

What was Solvonis Therapeutics's last closing price?

0.10p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Solvonis Therapeutics next report results?

Results are expected on 30 Jun 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.